Allogeneic LMP1 LMP2-Specific Cytotoxic T-Lymphocytes
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Biological Agent ->
Allogeneic Lymphocytes -> Allogeneic LMP1 LMP2-Specific Cytotoxic T-Lymphocytes
Allogeneic LMP1 LMP2-Specific Cytotoxic T-Lymphocytes Definition
A preparation of cytotoxic T-lymphocytes (CTL), specifically reactive to the Epstein-Barr virus (EBV) latent membrane proteins (LMP) 1 and 2, with potential antineoplastic activity. Peripheral blood mononuclear cells (PBMC) are collected from a donor and are exposed ex vivo to dendritic cells (DCs) transfected with a replication-deficient adenovirus encoding EBV LMP1/2 to generate LMP1/2-specific CTL which are subsequently expanded. Administration of allogeneic LMP1-/LMP2- specific CTL to patients with LMP1/2-positive tumors may result in a specific CTL response against tumor cells expressing LMP1 and LMP2, resulting in cell lysis and inhibition of tumor cell proliferation. As tumor associated antigens (TAAs), LMP1 and LMP2 are expressed in various malignancies including nasopharyngeal cancer and EBV-positive Hodgkin lymphoma.
Allogeneic LMP1 LMP2-Specific Cytotoxic T-Lymphocytes Synonyms
Allogeneic LMP1/LMP2-Specific Cytotoxic T-Lymphocytes
Terms in Allogeneic LMP1 LMP2-Specific Cytotoxic T-Lymphocytes category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.